ATE204083T1 - Herpes simplex viren diagnostik - Google Patents

Herpes simplex viren diagnostik

Info

Publication number
ATE204083T1
ATE204083T1 AT96921704T AT96921704T ATE204083T1 AT E204083 T1 ATE204083 T1 AT E204083T1 AT 96921704 T AT96921704 T AT 96921704T AT 96921704 T AT96921704 T AT 96921704T AT E204083 T1 ATE204083 T1 AT E204083T1
Authority
AT
Austria
Prior art keywords
herpes simplex
simplex virus
hsv
methods
infection
Prior art date
Application number
AT96921704T
Other languages
English (en)
Inventor
Rae Lyn Burke
D Anna Alexander
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE204083T1 publication Critical patent/ATE204083T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/705Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56994Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Luminescent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96921704T 1995-07-28 1996-06-20 Herpes simplex viren diagnostik ATE204083T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50859895A 1995-07-28 1995-07-28
US08/613,235 US5965354A (en) 1995-07-28 1996-03-08 Herpes simplex virus diagnostics
PCT/US1996/010615 WO1997005488A1 (en) 1995-07-28 1996-06-20 Herpes simplex virus diagnostics

Publications (1)

Publication Number Publication Date
ATE204083T1 true ATE204083T1 (de) 2001-08-15

Family

ID=27056239

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921704T ATE204083T1 (de) 1995-07-28 1996-06-20 Herpes simplex viren diagnostik

Country Status (11)

Country Link
US (1) US5965354A (de)
EP (1) EP0842430B1 (de)
JP (1) JPH11510893A (de)
AT (1) ATE204083T1 (de)
AU (1) AU6284996A (de)
CA (1) CA2227844A1 (de)
DE (1) DE69614393T2 (de)
ES (1) ES2159032T3 (de)
GR (1) GR3037090T3 (de)
PT (1) PT842430E (de)
WO (1) WO1997005488A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384640B1 (en) * 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
WO2002033418A1 (en) * 2000-10-17 2002-04-25 Besst-Test Aps Assay for directly detecting a biological cell in a body fluid sample
WO2002098369A2 (en) 2001-06-07 2002-12-12 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
JP2004535187A (ja) 2001-06-07 2004-11-25 ワイス・ホールデイングス・コーポレーシヨン アジュバントとしてのコレラホロトキシンの突然変異形
JP2006511790A (ja) * 2002-11-14 2006-04-06 サイファージェン バイオシステムズ インコーポレイテッド 羊膜内炎症のためのバイオマーカー
CN101824409B (zh) * 2003-04-25 2015-11-25 贝克顿·迪金森公司 通过核酸扩增检测1型和2型单纯疱疹病毒
US7763460B2 (en) 2005-06-24 2010-07-27 Focus Diagnostics, Inc. Methods and compositions for detecting herpes simplex virus type 2
KR101352238B1 (ko) * 2007-04-04 2014-01-15 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 단순포진바이러스 감염 치료를 위한 비특이적 지연형 과민증 반응
WO2015095366A1 (en) 2013-12-18 2015-06-25 Board Of Trustees, Southern Illinois University A rapid and sensitive serological assay to determine if patients are infected with herpes simplex virus type 1 (hsv-1) and/or type 2 (hsv-2)
EP3261654B1 (de) 2015-02-26 2021-08-11 Squarex, LLC Nichtspezifische verzögerte überempfindlichkeitsreaktion zur behandlung von infektionen mit dem herpes-simplex-virus
CN108779151B (zh) * 2016-02-01 2022-12-13 辛普勒夏雅公司 截短型单纯疱疹病毒2型糖蛋白g
SG11202101551TA (en) * 2018-05-17 2021-03-30 Immunome Inc Ch3 domain epitope tags

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US6100064A (en) * 1984-04-06 2000-08-08 Chiron Corporation Secreted viral proteins useful for vaccines and diagnostics
US4764459A (en) * 1984-12-28 1988-08-16 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-linked immunosorbent assay (ELISA) for determining anti-bodies against herpes simplex virus (HSV) types 1 and 2 in human sera
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
WO1991017443A1 (en) * 1990-05-04 1991-11-14 E.I. Du Pont De Nemours And Company A method of determining type specific antibodies to herpes simplex virus types 1 and 2
CA2088600C (en) * 1990-08-02 1999-11-16 Rae L. Burke Herpes simplex virus vp16 vaccines

Also Published As

Publication number Publication date
WO1997005488A1 (en) 1997-02-13
AU6284996A (en) 1997-02-26
ES2159032T3 (es) 2001-09-16
DE69614393D1 (de) 2001-09-20
US5965354A (en) 1999-10-12
EP0842430B1 (de) 2001-08-08
JPH11510893A (ja) 1999-09-21
CA2227844A1 (en) 1997-02-13
DE69614393T2 (de) 2001-11-22
PT842430E (pt) 2001-11-30
GR3037090T3 (en) 2002-01-31
EP0842430A1 (de) 1998-05-20

Similar Documents

Publication Publication Date Title
Grangeot-Keros et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women
DE69614393D1 (de) Herpes simplex viren diagnostik
Ashley Laboratory techniques in the diagnosis of herpes simplex infection.
CA2075183A1 (en) Specimen test slide and method of testing for fecal occult blood
Schmid et al. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2
NZ306051A (en) Testing using electrochemiluminescence
IL80660A0 (en) Method and device for the determination of gram negative bacteria in urine
DE3485653D1 (de) Verfahren und vorrichtung zur messung des reaktionsgrades zwischen antigenen und zell-leukozytenantikoerpern.
WO2004048600A3 (en) Diagnostic tests and methods for diagnosing inflammatory bowel disease
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
Genser et al. Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard
Dalessio et al. Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot
PT946874E (pt) Diagnostico de helicobacter pylori
CN114280298A (zh) 一种用于多病原体的IgM和IgG共检测的免疫层析试剂盒
SE8900721D0 (sv) Methods for detection of antibodies to
Safrin et al. Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS
Janier et al. Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris
Ashley et al. Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection
CN216900577U (zh) 一种用于多病原体的IgM和IgG共检测的免疫层析试剂盒
CA2276491A1 (en) Early detection of mycobacterial disease
Gutiérrez et al. Behaviour of IgG antibody avidity for the antigen and of IgA antibody in active cytomegalovirus, Epstein-Barr virus, herpes simplex virus and human herpes virus 6 infections. Adaptation of a commercial test
CA2174212A1 (en) Assay to detect hcv receptor binding
KR20150004491U (ko) 비인두암 진단 방법 및 진단 장치
Shekarchi et al. Comparison of enzyme-linked immunosorbent assay with enzyme-linked fluorescence assay with automated readers for detection of rubella virus antibody and herpes simplex virus
Kiefer et al. Normalized enzyme-linked immunosorbent assay for determining immunoglobulin G antibodies to cytomegalovirus

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee